BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 30, 2011
View Archived Issues
U.S. study describes new radiosensitizer's mode of action
Read More
New suicide gene strategy shows promise as safety switch for cell therapy
Read More
PMI inhibitor improves N-glycosylation in model of glycolytic disorders
Read More
Combination therapy for radiation sickness shows promise in mice
Read More
Phase III BTOG2 trial assesses combination therapies for advanced lung cancer
Read More
Dengue virus vaccine assessed in healthy volunteers
Read More
Study evaluates repeated daily oxytocin as a therapy for anxiety
Read More
New peptides with anxiolytic activity designed in Japan
Read More
Avidin discloses novel matrix metalloproteinase inhibitors
Read More
Emergent BioSolutions advances TRU-016 into phase II for leukemia indication
Read More
Merck & Co. patents new soluble guanylate cyclase activators
Read More
Toray, Japan Tobacco and Torii terminate joint development of TRK-820
Read More
Prima Biomed provides update on oral cervical cancer vaccine program
Read More
Recruitment begins in phase II SyB L-0501 trial in Japan
Read More
Axelar advances phase II AXL-1717 trial in lung cancer
Read More
Collaborating Japanese companies present new antioxidants
Read More
Novel MOMP-based products claimed at University of Surrey
Read More
RegeneRx aims to close licensing deal for ophthalmic drug candidate
Read More
FDA approves test to detect Staphylococcus infection
Read More
Gilead Sciences synthesizes novel compounds for hepatitis C
Read More
New Quidel assay approved for U.S. market
Read More
Cynapsus Therapeutics secures funds to develop sublingual Parkinson's disease drug
Read More
Alexion Pharmaceuticals announces planned acquistion
Read More
University of Colorado prepares new histone deacetylase inhibitors
Read More
Peregrine provides update on phase II bavituximab trial in hepatitis
Read More
Janssen submits supplemental NDA for Xarelto
Read More